Identification of Human Cathelicidin Peptide LL-37 as a Ligand for Macrophage Integrin ΑMβ2 (Mac-1, CD11b/CD18) That Promotes Phagocytosis by Opsonizing Bacteria

Research and Reports in Biochemistry
doi 10.2147/rrbc.s107070
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Integrin αL (CD11A); Integrin Β2 (LFA-1; MAC-1; CD18)

Science-Business eXchange
2011English

Mac-1 (CD11b/CD18) as Accessory Molecule for Fc R (CD89) Binding of IgA

Journal of Immunology
AllergyImmunology
2002English

A mAb to the 2-Leukocyte Integrin Mac-1 (CD11b/CD18) Reduces Intimal Thickening After Angioplasty or Stent Implantation in Rabbits

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1998English

Folate Receptor Β Regulates Integrin CD11b/CD18 Adhesion of a Macrophage Subset to Collagen

Journal of Immunology
AllergyImmunology
2016English

Modulation of Exogenous Antibiotic Activity by Host Cathelicidin LL-37

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica
ImmunologyAllergyMicrobiologyMedicineForensic MedicinePathology
2010English

Impaired Transendothelial Migration by Neonatal Neutrophils: Abnormalities of Mac-1 (CD11b/CD18)-dependent Adherence Reactions

Blood
BiochemistryImmunologyCell BiologyHematology
1990English

Upregulation of Human Β-Defensin-3 and Cathelicidin LL-37 in Kaposi’s Sarcoma

F1000Research
GeneticsMolecular BiologyPharmacologyBiochemistryMicrobiology ImmunologyMedicineToxicologyPharmaceutics
2012English

Transformation of Human Cathelicidin LL-37 Into Selective, Stable, and Potent Antimicrobial Compounds

ACS Chemical Biology
BiochemistryMedicineMolecular Medicine
2014English

Degradation of Human Antimicrobial Peptide LL-37 by Staphylococcus Aureus-Derived Proteinases

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2004English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy